Skip to main content

Posts tagged with "The Dark Side"

  • The Dark Side

    Dupeless Needication

    Here are two papers have been going around on Twitter for a few days now. The first one is from a Hindawi title, “The Scientific World Journal”, from a group at the University of Malaya. And the second is from the same team (several overlapping co-authors), published a year or so later in Scientific Reports. Neither… Read More
  • Business and Markets

    A Biotech Center In. . .Northern Vermont?

    Have a look at this article from Bloomberg Businessweek, which is mostly about the abuse of a visa program (EB-5) meant to encourage investment in out-of-the-way or economically depressed areas of the US. That’s not necessarily a bad idea, but it seems to have been an invitation to a lot of abuse over the years… Read More
  • The Dark Side

    Pfizer Fires For Fakery

    Today’s second “bad behavior” story comes courtesy of Retraction Watch and Leonard Schneider’s For Better Science. Schneider has been tracking some problems with papers from Min-Jean Yin, who was working at Pfizer’s La Jolla site. Five papers that came out of her work there are now being retracted – duplicate im… Read More
  • Regulatory Affairs

    Act Now And We’ll Throw In This Dead Arachnid

    I have a couple of bad-behavior stories today. The first (via ChemJobber’s Twitter feed) is from the FDA. They were inspecting – well, OK, trying to inspect – a Japanese facility owned by Nippon Fine Chemical, supplying APIs (active pharmaceutical ingredients/intermediates) to both the US and Japanese markets. (Readers outside the… Read More
  • Business and Markets

    China’s Internal Drug Market: A Mess

    This story has been making the rounds the last few days, and it’s interesting on several levels. A report in the Chinese newspaper Economic Information Daily says that the Chinese SFDA (State Food and Drug Administration) has been conducting a review of Chinese clinical trial practices, and after reviewing 1,622 trials has found that most of… Read More
  • The Dark Side

    A Good Old Fashioned Election

    You’d think that if someone was going to rig an election for a scientific society, they’d be. . .well, more scientific about it than this. Science reports that the Society for Biological Inorganic Chemistry has invalidated their recent officer election because things looked just a tiny bit suspicious: Counting revealed far more votes th… Read More
  • Aging and Lifespan

    A Shady Trial?

    The “young blood” research field is moving right along, but there are reasons to wonder about some of the directions it’s moving in. I’m referring, of course, to the results that have shown profound effects of younger plasma on older animals, and the big question is what the effects are on older humans. The Stanford… Read More
  • Drug Development

    Let’s Just Declare This a Clinical Candidate, Shall We?

    A longtime reader sent along a discussion he’d had recently about the “December Effect”. That has different names in different companies, but it refers to a situation that many people (especially those working for a large drug company) have experienced. If you’re at one of those big companies, you have targets for how many… Read More
  • The Dark Side

    The University of Malaya Is Not Having It

    Much faster than I (or probably anyone) expected, the University of Malaya has investigated the papers written about here and here, and concluded that yes indeed, they are full of fraudulent images. Retraction Watch has the story here, and here’s the statement from the university. They’re asking the authors to immediately retract all th… Read More
  • The Dark Side

    Crap, Courtesy of a Major Scientific Publisher

    I hate to be like this. But yesterday a number of chemists began noticing this paper, and after having a look, I think it really needs to be mentioned. (Update: if that link is down, and it’s been spotty under all the attention, try this one). It’s a group from Kuala Lumpur, the pharmacology department… Read More